Tag: Novo Nordisk A/S

Eli Lilly’s weight loss drug slashes the risk of developing diabetes in long-term trial

What’s next for the Biden administration’s Medicare drug price negotiations

Federal Trade Commission to sue drug middlemen over prices of medications including insulin, source says

Novo Nordisk’s Wegovy weight loss drug approved in China

Weight loss drug Wegovy is now approved for heart health — but that won’t mean broad insurance coverage just yet

Weight loss drugs are still hard to find — but Novo Nordisk and Eli Lilly are trying to change that

The weight loss drug market may soon get more crowded. Here are the companies trying to enter the booming space

FDA approves Eli Lilly’s tirzepatide for weight loss, paving way for wider use of blockbuster drug

Ozempic, Wegovy may curb drinking, smoking and other addictive behaviors – here’s what we know